Recursion Pharmaceuticals
RXRX
#3895
Rank
$2.33 B
Marketcap
$9.97
Share price
-1.97%
Change (1 day)
55.30%
Change (1 year)

Revenue for Recursion Pharmaceuticals (RXRX)

Revenue in 2023 (TTM): $43.87 M

According to Recursion Pharmaceuticals's latest financial reports the company's current revenue (TTM) is $43.87 M. In 2022 the company made a revenue of $39.68 M an increase over the years 2021 revenue that were of $10 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Recursion Pharmaceuticals from 2020 to 2023

Annual revenue

Year Revenue Change
2023 (TTM)$43.87 M10.57%
2022$39.68 M296.81%
2021$10 M193%
2020$3.41 M